Carcinoembryonic Antigen Market Scope And Analysis

  • Report Code : TIPRE00005405
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Carcinoembryonic Antigen (CEA) Market Scope and Key Players Analysis by 2031

Buy Now

Carcinoembryonic Antigen (CEA) Market Report Carcinoembryonic Antigen (CEA) Market Size and Share Carcinoembryonic Antigen (CEA) Market Scope and Analysis

Carcinoembryonic Antigen (CEA) Market Report Scope

Report Attribute Details
Market size in 2024 US$ 2.41 Billion
Market Size by 2031 US$ 3.68 Billion
Global CAGR (2025 - 2031) 6.20%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Test Type
  • ELISA
  • Radioimmunoassay
  • Fluorescence Immunoassay
By Application
  • Colorectal Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Lung Cancer
By End Use
  • Hospitals
  • Diagnostic Centers
  • Research and Academic Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F Hoffmann La Roche Ltd
  • Abbott
  • Quest Diagnostics Incorporated
  • RayBiotech Inc
  • Prospec Tany Technogene Ltd
  • Correlogic Systems Inc
  • GenWay Biotech Inc
  • Merck KGaA
  • Lee BioSolutions